Investing.com - Outset Medical (NASDAQ: OM) reported fourth quarter EPS of $-0.59, $0.05 better than the analyst estimate of $-0.64. Revenue for the quarter came in at $30.5M versus the consensus estimate of $30.13M.
Guidance
Outset Medical sees Q1 2024 revenue of $145.00M-$153.00M
Outset Medical's stock price closed at $3.21. It is down -37.43% in the last 3 months and down -86.45% in the last 12 months.
Outset Medical saw 4 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Outset Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Outset Medical's Financial Health score is "fair performance".
Check out Outset Medical's recent earnings performance, and Outset Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar